AMANDA HALTIWANGER: Open Payments
NPI 1649432477 · PROSPERITY, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$984 in 55 payments from 20 companies in 2025. Trend: 2023 $1,314 · 2024 $894 · 2025 $984
Food & beverage: $984
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $158 |
| ABBVIE INC. | 10 | $145 |
| Novo Nordisk Inc | 9 | $139 |
| PFIZER INC. | 6 | $110 |
| Esperion Therapeutics, Inc. | 3 | $57 |
| Amgen Inc. | 3 | $55 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| Verona Pharma, Inc. | 2 | $45 |
| Corcept Therapeutics | 2 | $30 |
| Recor Medical Inc | 1 | $23 |
Products named: FARXIGA, UBRELVY, Wegovy, NEXLETOL, QULIPTA, Kerendia, Ohtuvayre, Ozempic.
Industry payments across SC — which companies pay providers there.
